United States

Ranbaxy Laboratories Ltd (RANB.NS)

RANB.NS on National Stock Exchange of India

1 Apr 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Daiichi Sankyo announces outcome of arbitration proceeding with Ranbaxy
Friday, 6 May 2016 03:55am EDT 

Daiichi Sankyo Co Ltd <4568.T>: Says Daiichi Sankyo received a final award in the arbitration that it filed with the International Court of Arbitration of the International Chamber of Commerce in November 2012 against the former shareholders Ranbaxy Laboratories Ltd.[RANB.NS] on May 3 . Says they filed Ranbaxy concealed and misrepresented certain critical information concerning US Food and Drug Administration and Department of Justice investigations at the time of Daiichi Sankyo’s purchase of shares of Ranbaxy . Says Ranbaxy to pay Daiichi Sankyo 25.63 billion Indian rupees as compensatory damages and 8.51 billion Indian rupees as interest .Says Ranbaxy to pay Daiichi Sankyo $14.5 million for attorneys’ fees and expenses and $599,250 for arbitration costs which were incurred by Daiichi Sankyo.  Full Article

Ranbaxy Laboratories Ltd - Sun Pharmaceutical Industries Ltd recalls anti-allergic drug in US - Times of India
Tuesday, 27 Oct 2015 10:33pm EDT 

Ranbaxy Laboratories Ltd:Sun Pharma has initiated a recall of over a million packs of anti-allergic Loratadine drug from the US market after checks reportedly revealed the tablets were 'super potent' and 'out of specification' - Times of India.Loratadine tablets are manufactured and distributed in the US market by Ohm Laboratories, US-based subsidiary of Ranbaxy. Loratadine is generic version of Bayer's Claritin drug - Times of India.Sun Pharma acquired Ranbaxy in a $4 billion deal in April 2014, making it the largest domestic pharma company by sales - Times of India.  Full Article

Ranbaxy Laboratories Ltd products on FSSAI blacklist - Indian Express
Monday, 8 Jun 2015 08:00pm EDT 

Ranbaxy Laboratories Ltd:Says national food regulator handed over to states a blacklist containing multivitamin products from Ranbaxy - Indian Express.The list of around 500 products rejected by Food Safety and Standards Authority of India (FSSAI) was handed over to food safety commissioners.Many of the products on the FSSAI list were found to contain high levels of sugar, caramel, salt or heavy metals, caffeine and iron fillings.Says FSSAI list also includes at least 150 supplements, hair growth products, immune-booster tablets, metabolism-enablers, beauty-enhancers, vitamin sprays, wellness products, natural fruit enzyme supplements and protein, including tablets and capsules of Ranbaxy's Revital.  Full Article

More From Around the Web